Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis

Erkes, D. A., Cai, W., Sanchez, I. M., Purwin, T. J., Rogers, C., Field, C. O., Berger, A. C., Hartsough, E. J., Rodeck, U., Alnemri, E. S. and Aplin, A. E.  Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis. Cancer Discovery. 2019; 10(2), 254-269.  doi: 10.1158/2159-8290.cd-19-0672

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.